<DOC>
	<DOCNO>NCT00266357</DOCNO>
	<brief_summary>A study evaluate efficacy , safety tolerability MK-0928 Primary Insomnia .</brief_summary>
	<brief_title>Sleep Laboratory Study MK0928 Adult Patients With Primary Insomnia ( 0928-041 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<criteria>Patients diagnosis primary insomnia Patients active psychiatric disorder primary insomnia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>